L Schneider

Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study

M.A. Valantin, Sidonie Lambert-Niclot, Philippe Flandre et al. · Journal of Antimicrobial Chemotherapy · 2011 · 66 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia

Christine Katlama, Cathia Soulié, Fabienne Caby et al. · Journal of Antimicrobial Chemotherapy · 2016 · 49 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies

Pierre Frange, Lambert Assoumou, Diane Descamps et al. · Journal of Antimicrobial Chemotherapy · 2015 · 44 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Impact of Insertions in the HIV-1 P6 Ptapp Region on the Virological Response to Amprenavir

Stéphane Lastère, Cécile Dalban, Gilles Collin et al. · Antiviral Therapy · 2004 · 20 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +17

Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations

Romain Palich, Marc Wirden, Gilles Peytavin et al. · Journal of Antimicrobial Chemotherapy · 2020 · 19 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +17